Related Experiment Video
Updated: May 6, 2026
02:34
Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
Published on: May 10, 2024
2.3K
Inhaled corticosteroids for chronic obstructive pulmonary disease.
Mario Cazzola1, Paola Rogliani, Lucia Novelli
1University of Rome 'Tor Vergata', Unit of Respiratory Clinical Pharmacology, Department of System Medicine , Via Montpellier 1, 00133 Rome , Italy mario.cazzola@uniroma2.it.
Expert Opinion on Pharmacotherapy
|October 22, 2013
Summary
Inhaled corticosteroids (ICSs) benefit specific chronic obstructive pulmonary disease (COPD) patients, particularly frequent exacerbators. Identifying which COPD patients benefit from ICS therapy is crucial for effective treatment.
Area of Science:
- Pulmonary Medicine
- Pharmacology
Background:
- Current guidelines recommend inhaled corticosteroids (ICSs) for moderate-to-severe chronic obstructive pulmonary disease (COPD).
- Concerns exist regarding side effects of long-term ICS use and universal treatment applicability.
Purpose of the Study:
- To review evidence on the effects of ICSs in COPD treatment.
- To identify patient subsets that benefit from ICS therapy.
Main Methods:
- Focus on meta-analyses of published data and pooled analyses of primary data.
- Review of pipeline developments in COPD treatment.
Main Results:
- Evidence suggests ICSs benefit specific COPD patient subsets, including frequent exacerbators with chronic bronchitis and those with COPD-asthma overlap.
- Benefits include reduced lung function decline, fewer exacerbations, and improved quality of life.
Conclusions:
- The focus should shift from whether to use ICSs to identifying which COPD patients benefit.
- More research is needed to identify clinical features predicting ICS response in COPD.
More Related Videos
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
1.2K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
2.1K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
2.1K
01:23Inhaled Medications
1.1K
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
1.1K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.6K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K